Patofisiologi dan Tata Laksana Kardiotoksisitas yang Diinduksi Kemoterapi
MEDICINUS · 01.06.2026 · 39 (6) · 40-55
DOI: 10.56951/3hzabj15 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDICINUS, online erschienen am 01.06.2026. Verfasst von Helen Widiani und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
According to the European Society of Cardiology (ESC), cardiotoxicity is defined as damage of the function and/or structure of the heart associated with drug exposure, particularly anticancer therapies such as chemotherapy and radiotherapy,as well as damage caused by the cancer itself. Generally, chemotherapy-induced cardiotoxixity is classified into five types, with the two main types most frequently associated with high-risk antineoplastic therapy. Chemotherapy-inducedcardiotoxixity may occur through either direct or indirect mechanisms, with contributing factors including: accumulative dose, drug preparation, formulation, and drug delivery. The management of cardiotoxicity depends on the specific type ofcardiovascular disorder experienced by the patient. In cases of hypertension, angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs), along with dihydropyridine calcium channel blockers, are recommendedtherapeutic options. Anticancer therapy may be continued as long as the QT interval is ≤500 ms and the change in QT interval is
Zitieren
APA
Widiani, H., & Wibhuti, I. B. R. (2026). Patofisiologi dan Tata Laksana Kardiotoksisitas yang Diinduksi Kemoterapi. MEDICINUS, 39(6), 40-55. https://doi.org/10.56951/3hzabj15
Vancouver
Widiani H, Wibhuti IBR. Patofisiologi dan Tata Laksana Kardiotoksisitas yang Diinduksi Kemoterapi. MEDICINUS. 2026;39(6):40-55. doi:10.56951/3hzabj15
BibTeX
@article{Widiani2026,
author = {Widiani, Helen and Wibhuti, Ida Bagus Rangga},
title = {Patofisiologi dan Tata Laksana Kardiotoksisitas yang Diinduksi Kemoterapi},
journal = {MEDICINUS},
year = {2026},
volume = {39},
number = {6},
pages = {40--55},
doi = {10.56951/3hzabj15}
}
EUVIMED